<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04192929</url>
  </required_header>
  <id_info>
    <org_study_id>1912241137</org_study_id>
    <nct_id>NCT04192929</nct_id>
  </id_info>
  <brief_title>Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy</brief_title>
  <official_title>Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Narrow band imaging or electronic chromoendoscopy might provide similar adenoma detection
      capabilities while limiting time spent when compared to conventional chromoendoscopy method.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Randomization cards will be sealed and opened after the subject is deemed eligible for the study by the PI. This will be done in an area away from the subject but due to the nature of the study, PI can't be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Adenomas per colonoscopy</measure>
    <time_frame>during the procedure</time_frame>
    <description>total number of adenomas divided by total number of procedures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adenoma detection rate</measure>
    <time_frame>during the procedure</time_frame>
    <description>total number of patients with adenomas divided by total number of procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sessile serrated polyps per colonoscopy</measure>
    <time_frame>during the procedure</time_frame>
    <description>total number of sessile serrated polyps divided by total number of procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sessile serrated polyp detection rate</measure>
    <time_frame>during the procedure</time_frame>
    <description>total number of patients with sessile serrated polyps divided by total number of procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Withdrawal time</measure>
    <time_frame>during the procedure</time_frame>
    <description>Time from cecal intubation to end of the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspection time</measure>
    <time_frame>during the procedure</time_frame>
    <description>Time during withdrawal minus time for interventions including washing, suctioning and polypectomy or biopsies</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1065</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>High definition white light endoscopy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>colonoscopy performed using high definition equipment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chromoendoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>indigo carmine is sprayed on the colon mucosa during withdrawal phase</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Narrow band imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Narrow band imaging is used during withdrawal phase</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Narrow band imaging</intervention_name>
    <description>Blue light is used during withdrawal phase instead of the regular white light to highlight surface changes</description>
    <arm_group_label>Narrow band imaging</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chromoendoscopy</intervention_name>
    <description>Indigo carmine will be sprayed during withdrawal phase of colonoscopy</description>
    <arm_group_label>Chromoendoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High definition white light endoscopy</intervention_name>
    <description>High definition equipment will be used to perform colonoscopy</description>
    <arm_group_label>High definition white light endoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age â‰¥ 40 years

          2. Referral for screening, surveillance or diagnostic colonoscopy

        Exclusion Criteria:

          1. Inflammatory bowel disease

          2. History of colorectal cancer or colon resection

          3. Indication of positive FIT or cologuard

          4. Any colorectal cancer syndromes (FAP, HNPCC, SPS)

          5. Patient with poor bowel preparation identified during insertion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas Rex, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Krishna Vemulapalli, MBBS</last_name>
    <phone>3179480117</phone>
    <email>kvemulap@iu.edu</email>
  </overall_contact>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 6, 2019</study_first_submitted>
  <study_first_submitted_qc>December 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Douglas K. Rex</investigator_full_name>
    <investigator_title>Emeritus Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

